10534216|t|Haloperidol-induced torsade de pointes.
10534216|a|OBJECTIVE: To report a case of torsade de pointes related to the administration of high-dose intravenous haloperidol for the treatment of severe agitation. CASE SUMMARY: Reports in the literature of intravenous haloperidol-induced torsade de pointes are rare. We describe the case of a 41-year-old white woman with no predisposing factors who developed torsade de pointes 55 minutes after a dose of intravenous haloperidol 80 mg (total dosage 915 mg over 7 d). The results of the electrocardiogram were consistent with torsade de pointes and showed a prolonged QTc interval of 610 milliseconds. Intravenous magnesium sulfate 2 g/100 mL NaCl 0.9% was administered, which controlled the arrhythmia. The patient received one additional 80-mg haloperidol dose six hours after the arrhythmia-triggering dose, without reoccurrence of torsade de pointes. Haloperidol was then discontinued, and the patient had no further arrhythmias. CONCLUSIONS: Our case report and others from the literature suggest that intravenous haloperidol administration may prolong QT intervals in some patients, precipitating the potentially life-threatening arrhythmia torsade de pointes. Clinicians should be aware of haloperidol's potential to induce torsade de pointes, since it is used regularly for agitation and delirium in the critical care arena.
10534216	0	11	Haloperidol	Chemical	MESH:D006220
10534216	20	38	torsade de pointes	Disease	MESH:D016171
10534216	71	89	torsade de pointes	Disease	MESH:D016171
10534216	145	156	haloperidol	Chemical	MESH:D006220
10534216	185	194	agitation	Disease	MESH:D011595
10534216	251	262	haloperidol	Chemical	MESH:D006220
10534216	271	289	torsade de pointes	Disease	MESH:D016171
10534216	344	349	woman	Species	9606
10534216	393	411	torsade de pointes	Disease	MESH:D016171
10534216	451	462	haloperidol	Chemical	MESH:D006220
10534216	559	577	torsade de pointes	Disease	MESH:D016171
10534216	647	664	magnesium sulfate	Chemical	MESH:D008278
10534216	676	680	NaCl	Chemical	MESH:D012965
10534216	725	735	arrhythmia	Disease	MESH:D001145
10534216	741	748	patient	Species	9606
10534216	779	790	haloperidol	Chemical	MESH:D006220
10534216	816	826	arrhythmia	Disease	MESH:D001145
10534216	868	886	torsade de pointes	Disease	MESH:D016171
10534216	888	899	Haloperidol	Chemical	MESH:D006220
10534216	931	938	patient	Species	9606
10534216	954	965	arrhythmias	Disease	MESH:D001145
10534216	1052	1063	haloperidol	Chemical	MESH:D006220
10534216	1091	1103	QT intervals	Disease	OMIM:610141
10534216	1112	1120	patients	Species	9606
10534216	1169	1179	arrhythmia	Disease	MESH:D001145
10534216	1180	1198	torsade de pointes	Disease	MESH:D016171
10534216	1230	1241	haloperidol	Chemical	MESH:D006220
10534216	1264	1282	torsade de pointes	Disease	MESH:D016171
10534216	1315	1324	agitation	Disease	MESH:D011595
10534216	1329	1337	delirium	Disease	MESH:D003693
10534216	Positive_Correlation	MESH:D006220	MESH:D001145
10534216	Negative_Correlation	MESH:D006220	MESH:D003693
10534216	Positive_Correlation	MESH:D006220	MESH:D016171
10534216	Negative_Correlation	MESH:D008278	MESH:D001145
10534216	Positive_Correlation	MESH:D006220	OMIM:610141
10534216	Negative_Correlation	MESH:D012965	MESH:D001145
10534216	Negative_Correlation	MESH:D008278	MESH:D016171
10534216	Negative_Correlation	MESH:D006220	MESH:D011595

